raf inhibitors (Sugen/ASTA Medica)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameraf inhibitors (Sugen/ASTA Medica)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionOncogene proteins inhibitors
TargetsOncogene proteins
Therapy Area/IndicationsUrinary Bladder NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSugen Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSugen LlcAsta Medica Ag
Active IndicationsN/A
Inactive IndicationsUrinary Bladder NeoplasmsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A